Fully funded at-home kidney screening
Minuteful Kidney is available for all GP practices in Hampshire, Southampton, Isle of Wight CCG and Portsmouth CCG.
Set up the fully-funded service in under 1 hour
Hampshire, Southampton, Isle of Wight CCG and Portsmouth CCG has partnered with Healthy.io to allow people living with diabetes to take their annual urinary albumin:creatinine (ACR) test from the comfort of their own home.
Over 43,000 people in Hampshire, Southampton, Isle of Wight and Portsmouth CCG have still not yet completed their annual, NICE-recommended ACR test; putting them at increased risk for cardiovascular disease and kidney failure.
By shifting testing out of the practice and into patients’ homes, the Minuteful Kidney service has been shown to increase ACR uptake by 72%, helping to early detect chronic kidney disease (CKD) to improve the health and access to care for at-risk patients while freeing up valuable GP time.
The fully-funded service is delivered in partnership with NHS, the Accelerated Access Collaborative and the National Institute for Health Research (NIHR).
Why Minuteful Kidney
- Fully funded service by your CCG
- Supports practice workload - once set-up Healthy.io will manage the entire testing process
- Improves uptake of annual urinary ACR care process to ensure early identification of chronic kidney disease
- Quick and easy implementation
- Addresses backlogs in chronic disease management
- Integrates into SystmOne / EMIS
Send
We send Minuteful Kidney test kits directly to eligible patients' homes with their prior consent.
Test
Patients test at home using our kit and smartphone app, which guides them through the process.
Review
Test results are automatically sent to SystmOne or EMIS. Results can then be reviewed for follow up by the practice as appropriate.
found the test 'easy' or 'very
easy' to use
preferred testing at home
vs. testing at the clinic
would recommend this service
to a friend
Clinical-grade testing from home
The CKD early detection service increases adherence to annual urinary albumin to creatinine ratio (ACR) testing, which is known to be beneficial in the early detection and prevention of CKD, is recommended by NICE, and monitored by the National Diabetes Audit.
The test is built around the existing ACR point of care dipstick. It measures semi quantitative analysis of microalbumin (10 – 150 mg/L), creatinine (10 – 300mg/dL) and albumin to creatinine ratio (mg/mmol).
Results are expressed as ACR normal (<3 mg/mmol), ACR abnormal (3-30 mg/mmol) or ACR high abnormal (>30 mg/mmol).
The product is CE marked, GDPR compliant, and follows industry standards for privacy and safety.
Schedule a call to get started
This project is fully funded for all GP practices in Hampshire and Isle of Wight ICS.
Schedule a meeting with our team before 21st June to enrol with the service.
On the call our friendly team will talk you through the service offering, provide support with the onboarding process and give you the opportunity to ask any questions.
By providing this information, you consent to receive relevant content from Healthy.io. (You may opt out at any point.) For more information, visit our Privacy Policy.
- Judith Shore, Michelle Green, Andrew Hardy & Deborah Livesey (2019): The compliance and cost-effectiveness of smartphone urinalysis albumin screening for people with diabetes in England, Expert Review of Pharmacoeconomics & Outcomes Research, DOI: 10.1080/14737167.2019.1650024
